PolarityTE announced that it has entered into securities purchase agreements with a single healthcare-focused institutional investor […]
Profil has conducted over 30 biosimilar insulin trials and is the leading clinical research organization for studies related to diabetes. […]
BIOMERICS ANNOUNCES EXPANSION INTO IRELAND Expanding High-Performance Balloon Design & Development Capabilities in Galway […]
Co-Diagnostics announced that it has completed the principal design work of a PCR test for the monkeypox virus currently exhibiting a multi-country outbreak. […]
Marcy l’Étoile, France – bioMérieux, a world leader in the field of in vitro diagnostics, today announces that its BIOFIRE® Joint Infection (JI) Panel has received De Novo authorization from the US Food and Drug Administration (FDA). This panel tests for 31 pathogens implicated in most acute joint infections, and also includes 8 antimicrobial resistance (AMR) […]
PolarityTE announced that the Company will effectuate a 1-for-25 reverse stock split of the Company’s issued and outstanding common stock. […]
PolarityTE provided a business update and reported financial results for the three-month period ended March 31, 2022. […]
PolarityTE announced that the U.S. FDA granted a Regenerative Medicine Advanced Therapy (RMAT) designation to SkinTE under the Company’s open IND. […]
IONIQ Receives Three Awards including ‘Best Medical Technology Company 2022’ […]
RENOVA iStim™ implantable tibial neuromodulation device is being studied as a minimally invasive, patient-centric solution for the treatment of OAB. […]
New Executive Appointments Position ARUP Laboratories for Future Growth […]
Foldax announced that the first patients have been enrolled in the Drugs Controller General of India (DCGI)-approved clinical trial of the TRIATM biopolymer surgical aortic heart valve. […]